Erector Spinae vs. PENG Block for Total Hip Arthroplasty

Poznan University of Medical Sciences (PUMS)

Status and phase: Completed; Phase 4

Conditions: Hip Arthropathy; Hip Osteoarthritis; Hip Pain Chronic

Treatments: Drug: Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block; Drug: Control Test; Drug: Ropivacaine 0.2% Injectable Solution - PENG block

Study type: Interventional

Funder types: Other

Identifiers

NCT06083428

11/2023

Details and patient eligibility

About

Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty

Full description

Hip arthroplasty is one of the most common orthopedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prosthesis. Regional anesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.

In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasized. However, very few studies have evaluated the effect of various methods of anesthesia on the NLR.

This is the first study to investigate the effect of regional anesthesia on the NLR and PLR in patients undergoing hip replacement surgery.

Enrollment: 90 patients

Sex: All

Ages: 20 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with ASA classification I-III, Aged 20-90 years, Who will be scheduled for hip arthroplasty under spinal anesthesia.

Exclusion criteria

• Patients who have a history of bleeding diathesis, Take anticoagulant therapy, have a History of chronic pain before surgery, have Multiple trauma, cannot assess their pain (dementia), have been operated on under general anesthesia, have an infection in the area and do not accept the procedure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

90 participants in 3 patient groups

PENG Block group

Active Comparator group

Description:

ultrasound guided PENG block - 20ml 0,2% ropivacaine

Treatment:

Drug: Ropivacaine 0.2% Injectable Solution - PENG block

ESPB group

Active Comparator group

Description:

ultrasound guided erector spinae plane block - 20ml 0,2% ropivacaine

Treatment:

Drug: Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block

Control group

Active Comparator group

Description:

Only spinal anesthesia - No peripheral nerve block

Treatment:

Drug: Control Test